MR NO - CAS号查询

热门搜索化学品最多只显示前20条，请点击“搜索化学品”查看所有结果

CAS登录号

中文名

英文名

分子结构式

分子式

详情

供应商

60719-84-8

氨力农;
5-氨基-[3,4'双吡啶]-6(1H)-酮

AMRiNOne;
5-AmiNO-(3,4'-bipyridin)-6(1H)-one;
INOcor

AdeNOsine,N-(2,2-diphenylethyl)-;
CI 936;
MRS3310;
N6-(2,2-Diphenylethyl)adeNOsine

Acetamide,N-(1,6-dihydro-6-oxo[3,4'-bipyridin]-5-yl)-;
N-AcetylaMRiNOne

Benzoic acid,4-[(2-chloroethyl)(2-hydroxyethyl)amiNO]-;
MR 243

Carbamic acid,[3-(2-amiNOethyl)-1H-indol-5-yl]- (9CI);
5-CarboxyamiNOtryptamine;
MR 30143

Dipyrido[3,2-b:2',3'-i]pheNOxazin-13-ium,1-(3-carboxypropyl)-11-ethyl-1,2,3,4,8,9,10,11-octahydro-;
MR 121cation

L-Glutamic acid,N-[4-[(2-chloroethyl)(2-hydroxyethyl)amiNO]benzoyl]-;
MR 372

Morphinan-6-one,4,5-epoxy-3,14-dihydroxy-17-(2-methoxyethyl)-, (5a)- (9CI);
MR2264;
N-(2-Methoxyethyl)NOroxymorphone;
Semorphone

Morphinan-6-one,4,5-epoxy-3,14-dihydroxy-17-(2-methoxyethyl)-, (5a)- (9CI);
MR2264;
N-(2-Methoxyethyl)NOroxymorphone;
Semorphone

mO-CoNOtoxin MR VIA (reduced)(9CI);
24:PN: CN1982457 FIGURE: 1 unclaimed sequence;
449: PN: WO2008088422 SEQID: 464claimed sequence;
CoNOtoxin MRVIA (Conus marmoreus);
L-Valine,L-alanyl-L-cysteinyl-L-arginyl-L-lysyl-L-lysyl-L-tryptophyl-L-a-glutamyl-L-tyrosyl-L-cysteinyl-L-isoleucyl-L-valyl-L-prolyl-L-isoleucyl-L-isoleucylglycyl-L-phenylalanyl-L-isoleucyl-L-tyrosyl-L-cysteinyl-L-cysteinyl-L-prolylglycyl-L-leucyl-L-isoleucyl-L-cysteinylglycyl-L-prolyl-L-phenylalanyl-L-valyl-L-cysteinyl-;
Toxin m-MRVIA;
mO-CoNOtoxin (Conus marmoreusveNOm isoform MRVIA)

mO-CoNOtoxin MR VIB (reduced)(9CI);
163:PN: WO2009075773 FIGURE: 14 unclaimed sequence;
25: PN: CN1982457 FIGURE: 1unclaimed sequence;
74: PN: WO0149312 SEQID: 241 claimed sequence;
CoNOtoxinMarm14 (Conus marmoreus);
CoNOtoxin MRVIB (Conus marmoreus reduced);
CoNOtoxinMRVIB (Conus marmoreus);
L-Valine,L-alanyl-L-cysteinyl-L-seryl-L-lysyl-L-lysyl-L-tryptophyl-L-a-glutamyl-L-tyrosyl-L-cysteinyl-L-isoleucyl-L-valyl-L-prolyl-L-isoleucyl-L-leucylglycyl-L-phenylalanyl-L-valyl-L-tyrosyl-L-cysteinyl-L-cysteinyl-L-prolylglycyl-L-leucyl-L-isoleucyl-L-cysteinylglycyl-L-prolyl-L-phenylalanyl-L-valyl-L-cysteinyl-;
mO-CoNOtoxin (Conus marmoreusveNOm isoform MRVIB)

2-PropeNOic acid,2-methyl-, 2-[[bis(octyloxy)phosphinyl]oxy]ethyl ester;
MR 208

8H-ThieNO[2,3-b]pyrrolizin-8-one,3-(4-methoxyphenyl)-;
MR 16924;
NSC 676693

氨柔比星

AMRUBICIN;
(7S,9S)-9-Acetyl-9-amiNO-7-[(2-deoxy--D-erythro-pentopyraNOsyl)oxy]-7,8,9,10-tetrahydro-6,11-dihydroxy-5,12-naphthacenedione;
(7S)-9β-AmiNO-9-acetyl-7β-[(2-deoxy-β-D-erythro-pentopyraNOsyl)oxy]-7,8,9,10-tetrahydro-6,11-dihydroxynaphthacene-5,12-dione;
(7S,9S)-9-Acetyl-9-amiNO-7-(2-deoxy-β-D-erythro-pentopyraNOsyloxy)-6,11-dihydroxy-5,7,8,9,10,12-hexahydro-5,12-naphthacenedione;
(7S,9S)-9-AmiNO-9-acetyl-7-[(2-deoxy-β-D-erythro-pentopyraNOsyl)oxy]-7,8,9,10-tetrahydro-6,11-dihydroxynaphthacene-5,12-dione;
Amurubicin

aMRubiciNOl;
aMRubiciNOl;
(7S,9S)-9-AmiNO-7-[(2-deoxy--D-erythro-pentopyraNOsyl)oxy]-7,8,9,10-tetrahydro-6,11-dihydroxy-9-(1-hydroxyethyl)-5,12-naphthacenedione;
13-Hydroxy SM 5887;
AMRubiciNOl (Mixture of Diastereomers)

trans-3-Hydroxyhex-4-eNOic acid, min. 95 % (1H-NMR)

1,5-DIHYDRO-3-HYDROXY-8-METHYL[1,3,2]DIOXAPHOSPHEPINO[5,6-C]PYRIDIN-9-OL-3-OXIDE;
MRS 2219;
1,5-DIHYDRO-3-HYDROXY-8-METHYL[1,3,2]DIOXAPHOSPHEPINO[5,6-C]PYRIDIN-9-OL-3-OXIDE;
1,5-Dihydro-3,9-dihydroxy-8-methyl[1,3,2]dioxaphosphepiNO[5,6-c]pyridin-3-one;
Pyridoxine 4',5'-phosphoric acid

(1R,2S,4S,5S)-4-[2-IODO-6-(METHYLAMINO)-9H-PURIN-9-YL]-2-(PHOSPHONOOXY)BICYCLO[3.1.0]HEXANE-1-METHAN;
MRS 2500 TETRAAMMONIUM SALT;
(1R,2S,4S,5S)-4-[2-IODO-6-(METHYLAMINO)-9H-PURIN-9-YL]-2-(PHOSPHONOOXY)BICYCLO[3.1.0]HEXANE-1-METHANOL DIHYDROGEN PHOSPHATE ESTER TETRAAMMONIUM SALT;
(1R,2S,4S,5S)-4-[2-IODO-6-(METHYLAMINO)-9H-PURIN-9-YL]-2-(PHOSPHONOOXY)BICYCLO[3.1.0]HEXANE-1-METHANOL DIHYDROGEN PHOSPHATE ESTER TETRAAMMONIUM SALT;
(1R*,2S*)-4-[2-Iodo-6-(methylamiNO)-9H-purin-9-yl]-2-(phosphoNOoxy)bicyclo[3.1.0]hexane-1-methaNOldihydrogenphosphateestertetraammoniumsalt

SILVER NEODECANOATE;
SILVER RESINATE MR4704-P;
SILVER NEODECANOATE;
neodecaNOicacid,silver(1++)salt;
SilverneodecaNOateinxylene;
silver(1+) neodecaNOate;
Silver neodecaNOate, 25% in xylene;
Silver neodecaNOate, min. 97%

MRS-1191;
MRS-1191 \ A3 ADENODINE RECEPTOR ANTAGON IST

无

C31H27N1O4

详情

供应商

化工产品